View in EDS HTML Full Text PDF Full Text

Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.

Saved in:
Bibliographic Details
Title: Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.
Authors: Elmer LW; Department of Neurology, University of Toledo College of Medicine, 3120 Glendale Avenue, Toledo, OH, 43614, USA. Lawrence.Elmer@utoledo.edu., Juncos JL; Department of Neurology and Movement Disorders, Emory University School of Medicine, Atlanta, GA, USA., Singer C; Department of Neurology, University of Miami, Miami, FL, USA., Truong DD; The Parkinson's and Movement Disorder Institute, Fountain Valley, CA, USA., Criswell SR; Department of Neurology, Washington University, St. Louis, MO, USA., Parashos S; Struthers Parkinson's Center, Golden Valley, MN, USA., Felt L; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA., Johnson R; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA., Patni R; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.
Source: CNS drugs [CNS Drugs] 2018 Apr; Vol. 32 (4), pp. 399-400.
Publication Type: Journal Article; Published Erratum
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29637528
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Elmer+LW%22">Elmer LW</searchLink>; Department of Neurology, University of Toledo College of Medicine, 3120 Glendale Avenue, Toledo, OH, 43614, USA. Lawrence.Elmer@utoledo.edu.<br /><searchLink fieldCode="AU" term="%22Juncos+JL%22">Juncos JL</searchLink>; Department of Neurology and Movement Disorders, Emory University School of Medicine, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Singer+C%22">Singer C</searchLink>; Department of Neurology, University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Truong+DD%22">Truong DD</searchLink>; The Parkinson's and Movement Disorder Institute, Fountain Valley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Criswell+SR%22">Criswell SR</searchLink>; Department of Neurology, Washington University, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Parashos+S%22">Parashos S</searchLink>; Struthers Parkinson's Center, Golden Valley, MN, USA.<br /><searchLink fieldCode="AU" term="%22Felt+L%22">Felt L</searchLink>; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+R%22">Johnson R</searchLink>; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.<br /><searchLink fieldCode="AU" term="%22Patni+R%22">Patni R</searchLink>; Adamas Pharmaceuticals, Inc., Emeryville, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2018 Apr; Vol. 32 (4), pp. 399-400.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29637528
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40263-018-0510-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 399
    Titles:
      – TitleFull: Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Elmer LW
      – PersonEntity:
          Name:
            NameFull: Juncos JL
      – PersonEntity:
          Name:
            NameFull: Singer C
      – PersonEntity:
          Name:
            NameFull: Truong DD
      – PersonEntity:
          Name:
            NameFull: Criswell SR
      – PersonEntity:
          Name:
            NameFull: Parashos S
      – PersonEntity:
          Name:
            NameFull: Felt L
      – PersonEntity:
          Name:
            NameFull: Johnson R
      – PersonEntity:
          Name:
            NameFull: Patni R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2018 Apr
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1934
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: CNS drugs
              Type: main
ResultId 1